chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After 2nd set of immunizations, pt developed rash on both legs. (1/24/07)  Rash lasted for several days and eventually cleared.  Pt also developed coxsackie virus about a month later.  After 3rd set of immunizations,(4/4/07) the infant again developed a rash over legs, arms and face.  The rash occurred about 2 days after the immunizations.  Rash is small papules.
12 hour post vaccination starts shaving chills and mild myalgias. Took Tylenol with low grade temps. Overnight worsening myalgias, febrile to 101, nausea, headache despite Tylenol.
vision was shaky, unsteady and is progressing worse; headache; This spontaneous case was reported by a physician and describes the occurrence of VISUAL IMPAIRMENT (vision was shaky, unsteady and is progressing worse) and HEADACHE (headache) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VISUAL IMPAIRMENT (vision was shaky, unsteady and is progressing worse) and HEADACHE (headache). At the time of the report, VISUAL IMPAIRMENT (vision was shaky, unsteady and is progressing worse) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information was not reported.
tongue started to get a little bit of numbness and tingling/the numbness and tingling progressed to the roof of my mouth, my gums, my lower lip, underneath my tongue; tongue started to get a little bit of numbness and tingling/the numbness and tingling progressed to the roof of my mouth, my gums, my lower lip, underneath my tongue; numbness and tingling progressed up my cheeks and up underneath my eyes on both sides; numbness and tingling progressed up my cheeks and up underneath my eyes on both sides; This is a spontaneous report from a contactable nurse (patient). A 38-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in right arm on 26Dec2020 11:30 AM at single dose for covid-19 immunization. The COVID-19 vaccine was given at nurse's hospital vaccine clinic. Medical history included narcolepsy with cataplexy. Concomitant medication in two weeks included venlafaxine hydrochloride (EFFEXOR SR), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took naproxen and erythromycin; and experienced drug allergy.  On 26Dec2020, the patient stated "At about 1150 my tongue started to get a little bit of numbness and tingling. I didn't really feel nervous but I thought maybe some type of anxious reaction. So I thought I'd give it just a little time and over the next 20 minutes the numbness and tingling progressed to the roof of my mouth, my gums, my lower lip, underneath my tongue, up my cheeks and up underneath my eyes on both sides. I was not feeling anxious about the vaccination. I didn't have any trouble breathing or difficulty swallowing. It felt like Novocain that was wearing off like after you have dental work done. I decided to take 25mg Benadryl to see if it went away. And it definitely got better about 25 minutes after I took the Benadryl. Within an hour I would say it was 95% gone. Still just like a trace numbness on my cheeks. When I woke up this morning (27Dec2020) I noticed the facial numbness had completely resolved." The adverse event start time also reported as 11:45 AM. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered on 27Dec2020.  Information on the Batch/Lot number has been requested.
Have fever for last 14-15 hours, 102, 103, 101 like that; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received second dose of bnt162b2 (Solution injection; Batch/Lot number was not reported), via an unspecified route of administration on 25Mar2021 as single dose for covid-19 immunisation. Patient previously received first dose of bnt162b2 (Solution injection; Batch/Lot number was not reported), via an unspecified route of administration on 04Mar2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient reported that she got the second shot yesterday of the Pfizer COVID Vaccine and she was having fever since yesterday night, so she wanted to see if she can take Tylenol. She had fever for last 14-15 hours, 102, 103, 101 like that. She questioned if she can tylenol from medicine to bring the fever down. The patient underwent lab tests and procedures which included body temperature which was 102, 103 and 101. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Difficulty breathing at rest, seizures stroke symptoms electric schools in brain elevated inflammation markers, 6 months latter brain bleed related to inflammation storm
This spontaneous report as received from a registered pharmacist refers to a patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, route and lot# not reported). On an unknown date the patient experienced unspecified adverse reaction to ZOSTAVAX. The outcome of the event was unknown. It was unknown whether the patient sought medical attention. Additional information has been requested.
Right upper arm swelling in a 6" X 4" area with tenderness in the shoulder joint and swollen area that is a 6 on 1-10 scale that began at 4 pm on injection day and has persisted until today.
Dtap given was expired on 4-30-23.  No adverse s/s.
This spontaneous report was received from a female patient of unknown age via a company representative, regarding herself. Information on the patient's pertinent medical history, concurrent condition, concomitant medication and drug allergies/reactions were unknown by the reporter. On an unspecified date, the patient received the Human papillomavirus (HPV) vaccine (lot number, dose, frequency and route was not provided) for prophylaxis, after the age of 50. It was reported that it was unknown if the patient was administered with GARDASIL 9 (unidentified Merck HPV vaccine) or GARDASIL (unidentified Merck HPV vaccine). It was reported that the patient was an anal cancer survivor, however it was unknown if the patient was diagnosed with "anal cancer" before or after administration (anal cancer). The outcome of the event anal cancer was unknown. The causality assessment for the event of anal cancer was not provided. This report was not associated with a product quality complaint. Upon internal review, the event of anal cancer was determined to be medically significant.
They started on 3/17/2023. The biggest symptom was that I was dreadfully tired. I would get up at 6am and by 9am I would need to take a nap. I went to the doctor on 3/20/2023 and he prescribed amoxicillin. The symptoms last until roughly the 22nd. I did have some coughing as well.
Patient had redness and swelling at injection site. Reported fever and chills and aches overnite. Referred pt to see primary care physician.
1st dose 5Nov2021, 2nd not yet; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 5th November 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: 1st dose 5Nov2021, 2nd not yet). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 8-Mar-2023 The pharmacy technician asked that they need to restart the series or administer the 2nd dose now. The reporter consented to follow-up via postal. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
Pt received 2nd dose of SHINGRIX immunization on Saturday, 11/10/18. Afterwards, she started feeling weak and suffered from a headache. On Sunday, she discovered a quarter-sized rash approx. 2 inches below the injection site. Pt also described feeling warmth in her left arm and pain in joints through yesterday (11/13/18). Pt felt that rash may be spreading/"getting worse." Pharmacist recommended getting the rash checked out by a doctor. The pt, being a nurse, agreed that this was the best course of action. Pt also mentioned that she did not experience these side effects with the first injection.
ITCHY; painful rash. Moves to different areas of body about every 24-36 hrs. A couple of the rashes have stayed in one spot. Wrist and groin area. Some of the rash is barely visible; This is a spontaneous report from a contactable Consumer, the patient. A 54-year-old female non pregnant patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE,Lot number:unknown) via an unspecified route of administration on Left arm on 16Feb2021 at 02:30pm as a single dose for Covid-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number:unknown) via an unspecified route of administration on Left arm on 09Mar2021 at 03:15pm as a single dose for Covid-19 immunisation. The patients medical history includes lung cancer, end date was 2016, chronic lyme disease and Allergie to Doxycycline. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested positive for COVID-19 since having the vaccine. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient had received nexuim, supplements and crestor within 2 weeks of vaccination: On 28Feb2021 at 12:00 the patient experienced events of Itchy and painful rashes which Moves to different areas of body in about every 24-36 hrs a couple of the rashes have stayed in one spot in Wrist and groin area. Some of the rashes were barely visible but extremely itch. some was pink circle patches sized from nickel to quarter..not as painful, just as itchy. Had very slight reaction after first dose, after second dose, same evening it became much greater in numbers of rashes. The patient had not received any treatment for the reported events. The clinical outcome of the Itchy and painful rashe was not recovered at time of reporting. No follow-up attempts are possible; information about lot number cannot be obtained.
I woke up with a very plugged right ear, and the next day the left ear was plugged and my nose was running. Sunday, I had an episode of ataxia where I felt like I had been on a boat and couldn't get my balance. I needed help walking as my gait had me going to the left. This lasted about 7 hours. I went to Urgent Care about an hour into the imbalance. The doctor sent me to the emergency room by ambulance as he thought I had a stroke.
Sudden nausea, repeated vomiting for 2/12 hours, chills over the next several hours.
Tingling it tips of fingers both hands feeling like I was sick to my stomach achy --itching stiffness in fingers.
Patient had  Shingrix shot done last July. Stated that the injection gave him a lump since that time and subsequently got infected.
1 of 3 pts from the same Tetramune lot# who had adverse event;pt recvd vax 1SEP94;hrs later was lethargic & moaning, fever 102 during the noc;didn't sleep, moaning contd;given APAP;w/in 24hrs sxs abated;
One day post immunization, pt presented to urgent care clinic with an erythematous, swelling around injection site on left thigh. Pt also had some fever and poor feeding. On exam pt had left groin lymphadenopathy with approx 7x6cm area of induration and erythema. Pt was given Keflex x 5 days and Benadryl. Pt was seen one day later with improvement of symptoms.
32 yo F with PMH COVID 3/2020 with post COVID palpitations, reactive airway, sore throat and headaches, comes in for evaluation of palpitations, chest tightness, lightheadedness and headache that started soon after she got the second dose of the COVID vaccine around 5:45 pm.
Patient experienced pain at immunization site. Patient now reports tingling in hand, unable to grasp and hold playing cards
Within 2 hrs of getting vaccination, child woke up screaming at top of her lungs. lasted x1hr. Calmed down within 10 minutes cried with high pitch x 30 minutes; waves of crying; ok in between. Took 2-3 to be ok.
According to the patient, the administering pharmacist gave the first vaccination of the series SUBCUTANEOUS instead of INTRAMUSCULARLY.  Patient came for 2nd dose (3 months after incident) and made this known to the pharmacy staff. She complained of serious bruising and pain around the injection site.
Pain at the injection site was experienced immediately, but also was expected. Around 9:00 pm started experiencing fatigue. About midnight began to experience all-over muscle aches, fever, chills, shaking, and nausea. The symptoms were such that I had to stay home from work on Tuesday, January 19th. Today, Wednesday 20th, fever, chills, shaking and nausea are gone. Still feeling fatigued and generally weak.
2/14/2021 felt faint and shaky, lasted approximately 30 minutes, very weak and tired after this, MD appt on 2/16/2021 (previously scheduled, not for this) had an abnormal EKG, right bundle branch block.  No previous heart problems, no family history of heart problems.
I thought I was dying.; migraines; chills; fever; This case was reported by a consumer via interactive digital media and described the occurrence of migraine in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Moderna with an associated reaction of pain in extremity (had two Moderna vaccine shots on an unknown date, experienced nothing but a sore arm).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, between 3 and 4 weeks after receiving Shingles vaccine, the patient experienced migraine, chills, fever and impending doom. On an unknown date, the outcome of the migraine, chills and fever were recovered/resolved and the outcome of the impending doom was unknown.   It was unknown if the reporter considered the migraine, chills, fever and impending doom to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient for herself/himself. The age at vaccination was not reported. The patient stated that, 5 months after receiving 2 Moderna vaccine shots, the patient went to saw doctor on routine appointment and they suggested the patient to take Shingles vaccine and the 2nd one would be given in two months.  Well, for 3 and half weeks after receiving the Shingles vaccine, the patient thought he/she was dying, had 21 days of migraines, chills, fever, etc.  The patient could not figure it out why he/she had such a reaction, but the patient had a hard time deciding to go get the 3rd Moderna shot.
A report has been received from a Health Professional concerning a 30 year old, Female subject, who had been receiving Nasal FLUMIST QUADRIVALENT NE LIVE, INTRANASAL). FLUMIST QUADRIVALENT (INTRANASAL) started on 17-Sep-2013. The patient was administered two full doses of FLUMIST QUADRIVALENT, one in each nostril which started on 17-Sep-2013. The outcome of the event of TWO FULL DOSES OF FLUMIST QUADRIVALENT, ONE IN EACH NOSTRIL is unknown. The report is considered to be non-serious.
Developed whole body red rash at 4:00 PM, advised to give BENADRYL which helped rash. Next morning woke up with swollen eyelids and face, went to ER, given prednisone and BENADRYL.
Rash, itchy, started on arms, spread to legs. Rec. Benadryl, Zantac, oatmeal bath to relieve itch.
per patient:  Extreme cold chills, fever , dizziness and swollen hands & face   Spent full day Tuesday in the bed. Got up after 4pm , showered but too dizzy to accomplish anything ~ got back in the bed
Information has been received from a pharmacist concerning a 63 year old male who on 4/27/00 was vaccinated with 1 dose of pneumococcal vaccine 23 polyvalent in the left arm. On 4/30/00, the pt developed cellulitis at the injection site. The pt was seen in the ER and was placed on therapy with Keflex. The reporter stated that the pt's wife received a vaccination from the same lot number and multidose vial, but did not have a reaction. Additional information has been requested.
About 6 min after receiving the nasal H1N1 vaccine patient became flushed and red faced, also developed a red flat rash on back and arms. Also hot and sweaty. Patient had not eaten that am.
Right arm muscle pain from 2 hours after the vaccine (nov 30th) until today (dec 2nd) right armpit swelling and pain was noticed dec 1st in the morning and is still swollen and painful today (dec 2nd)
Patient reported facial swelling and throat tightness within 1 hour after vaccination. Patient treated herself with Benadryl at home. Patient advised not to receive second dose of vaccine.
This case was reported by a healthcare professional via sales representative and described the occurrence of swelling injection site in a 4-year-old female subject who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included HAVRIX; GlaxoSmithKline; unknown; unknown given on 24 July 2012; MMR vaccine (non-gsk); Merck; unknown; unknown given on 24 July 2012; VARIVAX (non-gsk); Merck; unknown, right arm given on 24 July 2012. There were no concurrent medications. On 24 July 2012 the subject received 1st dose of KINRIX (.5 ml, unknown, right deltoid). On 25 July 2012, 24 hours after vaccination with KINRIX, the subject experienced swelling injection site, injection site redness, injection site pain, pain in r arm on elevation, injection site blisters and blisters on arm. The subject received vaccinations on 24 July 2012, 24 hours later the subject had redness, swollen, multiple blisters and on large blister at the injection site. Pain occurred when the arm was extended above her head. The subject had lab work performed including white blood cell count that was within normal limits, ATB (antibiotic) was given. Demarcated region on arm. On 28 July 2012 the subject returned and arm had largely improved. Large blister ruptured and no other blisters except tiny ones. On 30 July 2012, the healthcare professional called the subject and was found to continue to improve. No further follow up information. On an unspecified date in 2012, the events were resolved. The healthcare professional considered the events were possibly related to vaccination with KINRIX.
PATIENT HAD LARGE RED SWOLLEN AREA EXTEDING UP ARM AND AROUND BACK OF ARM AND ON UPPER BACK.  SWOLLEN AND WARM TO THE TOUCH.
PT WAS DIAGNOSED WITH RSV AND INTUSSUSCEPTION ON 2-10-2013.
The night of my second dose I was awakened from a deep sleep with severe ringing in my ears. This tinnitus was so loud and overbearing that I was forced to turn on the television to ?mask? the ringing in order to go back to sleep. This only started after my 2nd dose and has continued ever since (it?s been 5 days now) without any signs of improvement. I have no history of tinnitus, nor have I ever been infected with Covid 19.
Large local reaction with swelling over entire right thigh (hip to knee). Irritable with pain in left thigh and crying for 3 hours. Area not red or warm. Swelling subsided over 3-4 days, no obvious pain the next day. Treated with analgesics and ice packs.
On 3/2/2021, I got my second dose of Moderna at 4:30PM. At 4:30AM on 3/3/2021, I woke up shaking, freezing, aching all over, nauseous, dizzy, sweating, and with an intense headache. I alternated between freezing and feeling as if I were burning up. The symptoms gradually worsened until about 10:30AM, when my husband took me to the ER at Hospital. When I got to the ER, I was hooked up to an IV, as I was a little dehydrated. I underwent a chest X-ray and bloodwork and was given a vitamin shot. The test results indicated no abnormalities. I was also given a sublingual tablet to treat my nausea. Since no abnormalities were detected in the tests, the doctors concluded that my symptoms were a reaction to the Moderna vaccine. I was kept for 3 hours in the ER and then released. The symptoms lasted all day, and I was given nothing to treat them save some sublingual anti-nausea tablets to take home. The symptoms were resolved by 3/4/2021, but I was so fatigued after my experience that I took off from work for 3 days.
Fever and tingling/burning sensation in hands and feet. Fever is lasted roughly 48hrs but the tingling/burning sensation is still present as of 08/05.
Fatigue and muscle ache morning after. Chills, Fever developing afternoon after injection. Took Tylenol
Pt inadvertantly given vaccine that was past BUD date. No ill effects noted at time of injection. Spoke with parent of child this am, denies child having any ill effects.
Approx 50 min after immuniz, pt developed continuous crying episode which lasted 2 hrs. Also had a high-pitched cry. No fever, leg slightly red & swollen at inject site. Mom applied ice compress to legs & treated w/Tylenol.
Approximatley six to seven days after MMR was given patient broke out in rash-red raised bumps on face and body.
This case was reported by a pharmacist via sales rep and described the occurrence of injection site rash in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX (subcutaneous) .5 ml. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site rash and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site rash and intramuscular formulation administered by other route were unknown. It was unknown if the reporter considered the injection site rash to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient received dose of SHINGRIX via the subcutaneous route, which led to incorrect route of vaccine administration. The patient developed a rash at the injection site. It was entered an MSL task regarding whether to be readministered or not. The reporter agreed to be followed up.